October 13, 2026 · Gastroenterology · DOI: 10.1053/j.gastro.2026.09.026

Myofibroblast Derived Transglutaminase 2 Activity is Upregulated in Stricturing Crohn's Disease and its Inhibition Exerts Anti-Fibrotic Properties.

Listen to this summary

Intestinal fibrosis in Crohn's disease is a major clinical problem, and this study asks whether transglutaminase 2 (TG2), an enzyme that can act directly on the extracellular matrix, drives fibrosis independently of inflammation. The authors found that TG activity was elevated in stricturing Crohn's disease, that myofibroblasts were the main TG2 source, and that TG2 inhibition or inducible knockout of TGM2 reduced matrix accumulation and experimental fibrosis without changing inflammation. These results suggest TG2 may contribute to inflammation-independent progression of intestinal fibrosis.

Jyotsna Chandra, Doug Czarnecki, Pranab K Mukherjee, Gail A West, Ilyssa O Gordon, Thomas Plesec, Yan Wang, Sinan Lin, Jie Wang, Marianne Bergin, Linghong Huang, Ren Mao, Nguyen Quang Tam, Weiwei Liu, William J Massey, Suhanti Banerjee, Ankita Prasad, Andrei I Ivanov, Samantha Gauriloff, Mark E Baker, Joseph Sleiman, Katherine Falloon, Claire A Beveridge, Catherine Larsen, Sean Kessler, Olga Lavryk, Jeremy Lipman, Stefan Holubar, Shaomin Hu, Claudio Fiocchi, Timothy Johnson, Carol de la Motte, Florian Rieder

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play